Home

Glaxosmithkline Pharmaceuticals Ltd Quarterly Result

Image

Glaxosmithkline Pharmaceuticals Ltd

NSE: GLAXO

Net Profit - Last Quarter

₹ 229.88 Cr.

Last updated on: Feb 23, 2025

Glaxosmithkline Pharmaceuticals Ltd Quarterly Results Key Highlights

  • The revenue of Glaxosmithkline Pharmaceuticals Ltd for the Dec '24 is ₹ 984.49 crore as compare to the Sep '24 revenue of ₹ 1050 crore.
  • This represent the decline of -6.24%a1# The ebitda of Glaxosmithkline Pharmaceuticals Ltd for the Dec '24 is ₹ 326.99 crore as compare to the Sep '24 ebitda of ₹ 360.94 crore.
  • This represent the decline of -9.41%a1# The net profit of Glaxosmithkline Pharmaceuticals Ltd for the Dec '24 is ₹ 229.88 crore as compare to the Sep '24 net profit of ₹ 252.5 crore.
  • This represent the decline of -8.96%a1#.

Glaxosmithkline Pharmaceuticals Ltd Quarterly Results Analysis

Market Price of Glaxosmithkline Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Glaxosmithkline Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Feb 20252508.8
20 Feb 20252569.45
19 Feb 20252510.2
18 Feb 20252529.7
17 Feb 20252332.25
14 Feb 20252017.75
13 Feb 20251995.65
12 Feb 20252031.5
11 Feb 20252056.25
10 Feb 20252141.55

Historical Revenue of Glaxosmithkline Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Glaxosmithkline Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Glaxosmithkline Pharmaceuticals Ltd

No data available

* All values are in crore

Glaxosmithkline Pharmaceuticals Ltd News Hub

Glaxosmithkline Pharmaceuticals consolidated net profit rises 37.87% in the June 2024 quarter

Net profit of Glaxosmithkline Pharmaceuticals rose 37.87% to Rs 182.33 crore in the quarter ended Ju

Read more

05 Aug 24

GSK Pharma Q1 PAT climbs 39% YoY to Rs 182 crore

Revenue from operations grew by 9.89% year on year (YoY) to Rs 811 crore during the quarter ended Ju

Read more

03 Aug 24

GlaxoSmithKline Pharmaceuticals to declare Quarterly Result

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 O

Read more

25 Oct 24

Board of GlaxoSmithKline Pharmaceuticals recommends Special Interim Dividend

GlaxoSmithKline Pharmaceuticals announced that the Board of Directors of the Company at its meeting

Read more

29 Oct 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

May 2024

Transcript

Mar 2023

Transcript

Aug 2021

PPT

FAQs for Quarterly Results of Glaxosmithkline Pharmaceuticals Ltd

What key financial metrics are included in Glaxosmithkline Pharmaceuticals Ltd's quarterly results?

Key financial metrics in Glaxosmithkline Pharmaceuticals Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Glaxosmithkline Pharmaceuticals Ltd announce its quarterly results?

Glaxosmithkline Pharmaceuticals Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Glaxosmithkline Pharmaceuticals Ltd's quarterly performance impact its stock price?

Glaxosmithkline Pharmaceuticals Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Glaxosmithkline Pharmaceuticals Ltd's quarterly results on dividends?

The impact of Glaxosmithkline Pharmaceuticals Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Glaxosmithkline Pharmaceuticals Ltd's quarterly results?

Yes, Glaxosmithkline Pharmaceuticals Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions